Rosacea: Pathogenesis and Therapeutic Correlates.
Geng RSQ, Bourkas AN, Mufti A, Sibbald RG.
J Cutan Med Surg. 2024 Mar-Apr;28(2):178-189. doi: 10.1177/12034754241229365. Epub 2024 Mar 7.
Rosacea.
Searle T, Al-Niaimi F, Ali FR.
Br J Hosp Med (Lond). 2021 Feb 2;82(2):1-8. doi: 10.12968/hmed.2020.0417. Epub 2021 Feb 27.
Rosacea.
van Zuuren EJ.
N Engl J Med. 2017 Nov 2;377(18):1754-1764. doi: 10.1056/NEJMcp1506630.
Neurogenic Rosacea Treatment: A Literature Review.
Ivanic MG, Oulee A, Norden A, Javadi SS, Gold MH, Wu JJ.
J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181.
Rosacea: Common Questions and Answers.
Frazier W, Zemtsov RK, Ge Y.
Am Fam Physician. 2024 Jun;109(6):533-542.
Recent advances in understanding and managing rosacea.
Buddenkotte J, Steinhoff M.
F1000Res. 2018 Dec 3;7:F1000 Faculty Rev-1885. doi: 10.12688/f1000research.16537.1. eCollection 2018.
Ocular rosacea.
Redd TK, Seitzman GD.
Curr Opin Ophthalmol. 2020 Nov;31(6):503-507. doi: 10.1097/ICU.0000000000000706.
Rosacea in children: a review.
Chiriac A, Wollina U.
Eur J Pediatr. 2023 Oct;182(10):4323-4328. doi: 10.1007/s00431-023-05083-0. Epub 2023 Aug 9.
Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea.
Tu KY, Jung CJ, Shih YH, Chang ALS.
Front Immunol. 2024 Jul 29;15:1403798. doi: 10.3389/fimmu.2024.1403798. eCollection 2024.
[Rosacea].
Huldt-Nystrøm T, Danielsen K, Li X, Stangeland KZ.
Tidsskr Nor Laegeforen. 2017 Oct 2;137(18). doi: 10.4045/tidsskr.16.0657. Print 2017 Oct 3.
